Alemtuzumab and multiple sclerosis: Is it safe?

Research output: Contribution to journalArticle

2 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)17-18
Number of pages2
JournalNeurology
Volume83
Issue number1
DOIs
StatePublished - Jul 1 2014

Fingerprint

Antibodies, Monoclonal, Humanized
Multiple Sclerosis
alemtuzumab

ASJC Scopus subject areas

  • Clinical Neurology
  • Arts and Humanities (miscellaneous)

Cite this

Alemtuzumab and multiple sclerosis : Is it safe? / Bourdette, Dennis.

In: Neurology, Vol. 83, No. 1, 01.07.2014, p. 17-18.

Research output: Contribution to journalArticle

@article{c4d2e16bda5e4c4fbd73e2d7de747e5c,
title = "Alemtuzumab and multiple sclerosis: Is it safe?",
author = "Dennis Bourdette",
year = "2014",
month = "7",
day = "1",
doi = "10.1212/WNL.0000000000000554",
language = "English (US)",
volume = "83",
pages = "17--18",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Alemtuzumab and multiple sclerosis

T2 - Is it safe?

AU - Bourdette, Dennis

PY - 2014/7/1

Y1 - 2014/7/1

UR - http://www.scopus.com/inward/record.url?scp=84903999246&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84903999246&partnerID=8YFLogxK

U2 - 10.1212/WNL.0000000000000554

DO - 10.1212/WNL.0000000000000554

M3 - Article

C2 - 24920853

AN - SCOPUS:84903999246

VL - 83

SP - 17

EP - 18

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 1

ER -